Loring Wolcott Coolidge Fiduciary Advisors Llpma buys $147,383,700 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Loring Wolcott Coolidge Fiduciary Advisors Llpma scooped up 9,090 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 26, 2016. The investment management firm now holds a total of 1,352,020 shares of Stryker Corporation which is valued at $147,383,700.Stryker Corporation makes up approximately 3.48% of Loring Wolcott Coolidge Fiduciary Advisors Llpma’s portfolio.

Stryker Corporation opened for trading at $109.33 and hit $110.22 on the upside on Monday, eventually ending the session at $109.94, with a gain of 0.85% or 0.93 points. The heightened volatility saw the trading volume jump to 9,17,423 shares. Company has a market cap of $41,115 M.

Other Hedge Funds, Including , Atria Investments reduced its stake in SYK by selling 3,992 shares or 39.54% in the most recent quarter. The Hedge Fund company now holds 6,104 shares of SYK which is valued at $667,778. Stryker Corporation makes up approx 0.07% of Atria Investments’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.